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Background: Sterile inflammation is a substantial element of post-stroke pathophysiology with the determination
of autoimmunity versus tolerance being one of its most important aspects. It is believed that this determination is
initiated relatively early after stroke onset by clearing macrophages and migratory dendritic cells (DC). However, the
phenotypic differentiation of macrophages and DC is intricate particularly in the disease context. Here, we utilized a
set of surface markers used in mucosal immunity research to investigate the involvement of macrophages and DC
subpopulations in post-stroke inflammation in mice.
Findings: Photothrombotic stroke induced a significant increase of lineage (CD3, B220, Ly6G and CD49b) negative
CD11b+ cells in the brain primarily consisting of F4/80+ macrophages and, to a lesser extent, F4/80-/CD11c-/
CD11b+monocytes and F4/80-/CD11c+ DC. The latter could be differentiated into the classical migratory DC
subpopulations (CD11b+ and CD103+), but no CD4 or CD8+ DC were found. Finally, stroke caused a significant
increase of CD11b/CD103 double-positive DC in the affected brain hemisphere.
Conclusions: The surface marker combination used in this study allowed a phenotypic differentiation of
macrophages and DC subpopulations after stroke, thus providing an important prerequisite to study post-stroke
immunity and tolerance.
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Ischemic tissue damage during cerebral stroke triggers a
prompt and long-lasting immune reaction that involves
virtually all parts of the innate and adaptive immune system.
The chronology of immune cell infiltration and the interplay
of immune cell subsets largely follow the generic course of
sterile tissue inflammation.
The mononuclear phagocyte family plays a pivotal role
for whether the adaptive immune system responds im-
munogenic or tolerogenic to ischemic cell death. Macro-
phages attenuate immunogenic cell death by phagocytosing
dying cells and debris, and promote tissue repair [1]. On
the other hand, migratory dendritic cells (DC) are capable
of transporting antigens towards the draining lymph nodes,
and initiate antigen-specific immune responses [2]. After
stroke, DC thus shape the adaptive immune reaction to
brain antigens either by promoting tolerance or by inducing* Correspondence: daniel-christoph.wagner@izi.fraunhofer.de
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outcome [3].
Though controversially discussed [4], the idea of a “func-
tional labor division” between macrophages and DC was
substantiated by the finding that different transcriptional
programs are expressed in both populations [5]. However,
despite these apparent functional differences, it is still
unclear if and how macrophages and DC could be pheno-
typically differentiated, especially during inflammation [6].
This shortcoming particularly applies for the ischemic
brain, where some evidence for DC activity and tolerance
induction exists [7,8], but detailed mechanistic studies are
currently hampered by a lack of specific DC markers.
Studies on the role of DC during post-stroke inflamma-
tion have been primarily based on the use of the integrin
CD11c [9,10], but this marker is co-expressed with CD11b
on macrophages and natural killer cells [6]. Macrophage
CD11c expression even seems to indicate a M1 polarization
[11] which sheds new light on the possible functions of
CD11c+ cells after stroke. To approach the problem of
macrophage and DC identity after stroke, we usedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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members of the mononuclear phagocyte system by
more specific combinations of surface markers.Methods
Animals and experimental stroke
The study conformed to the Guide for the Care and Use
of Laboratory Animals published by the US National
Institutes of Health (NIH Publication No. 85-23, re-
vised 1996) and was approved by local state authorities
(protocol number TVV10/13). Six male mice (C57BL/6,
Charles River Laboratories, Sulzfeld, Germany; 14
weeks old) were randomly assigned to a control group
(naive, n = 3) and a stroke group (photothrombosis,
PT, n = 3). The PT group was then replicated with
three additional animals (experiment 2). Animals were
singly housed with free access to food and water and
kept on a 12 h/12 h light-dark cycle. PT was induced
as described previously [12]. Briefly, mice were anes-
thetized with isoflurane (2%), injected with carprofen
(5 mg/kg bodyweight s.c.) and placed in a stereotactic
frame. The skull was exposed by midline incision and
a cold-light photodiode was placed 2.5mm right and
1mm posterior from Bregma. Five minutes after intra-
peritoneal injection of Bengal rose solution (0.1mL)
the brain was illuminated for 15 minutes.
Sampling
Animals were sacrificed six days after stroke by CO2 expos-
ure under deep isoflurane narcosis. The circulation was
transcardially perfused with 100 mL Hank's buffered salt so-
lution (HBSS, Sigma, Taufkirchen, Germany) before brains
were removed. Single brain hemispheres were manually and
enzymatically (Liberase TL, 2 U/mL, Roche, Mannheim,
Germany) homogenized in HBSS with calcium/magnesium.
Brain leukocytes were separated by Percoll solution (25%,
GE Healthcare, Munich, Germany) using density gradient
centrifugation as previously reported [13].
Flow cytometry
Cell suspensions were first incubated with an anti-mouse
CD16/CD32 Fc-receptor blocking reagent (eBioscience,
Frankfurt, Germany) for 10min before being labeled with
the following anti-mouse antibodies: F4/80-Alexa Fluor488
(AbD Serotec Kidlington, UK), CD4-PerCP, MHCII
(I-A/I-E)-PerCP, CD11b-APC, CD45.2-APC-eFluor780
(all eBioscience), CD11c-PE-Cy7, CD103-Pacific Blue
(both Biolegend, San Diego, USA), CD8-Horizon V500
(BD Biosciences, Heidelberg, Germany) and biotinylated
anti-lineage antibodies (CD3, B220, Ly6G, CD49b, all
ebioscience) followed by incubation with phycoerythrin-
labeled streptavidin (BD Biosciences). Flow cytometric
analyses were performed by an investigator blinded tothe group allocation using a 3-laser FACSCanto II (BD
Biosciences) and analyzed by FlowJo software (Tree
Star, Ashland, USA). The gating strategy is displayed in
Figure 1. Total brain leukocyte counts were deter-
mined by Trucount Tube measurement (BD Biosci-
ences) of CD45-labeled brain cell suspensions.
Statistics
Data were presented as mean ± standard deviation. Statis-
tical differences were determined by one-way ANOVA
followed by Bonferroni’s post hoc test. P-values of 0.05 or
less were considered statistically significant. Statistical ana-
lyses were performed by GraphPad Prism (Version 5.03, La
Jolla, USA).
Results
Brain infiltrating cells were defined as CD45high+ cells that
could be unambiguously differentiated from CD45 inter-
mediate (int) microglia (Figure 1, cell gate). Macrophages
were delineated as CD11b+/F4/80+ cells. The remaining
cells were then distinguished by a lineage (Lin) combination
(CD3, B220, Ly6G, CD49b) and CD11c. Lin-/CD11c-/
CD11b+ cells were categorized as monocytes, Lin-/CD11c+
as conventional DC (cDC) and Lin+ (B220+)/CD11c+ cells
as plasmacytoid DC (pDC; Figure 1, non-macrophage gate).
Flow cytometric quantification revealed a significant
increase of CD45+ cells in the ischemic hemisphere at
day 6 after stroke (naive: 115.2 ± 27.5 × 10E3 cells and PT
contralateral: 107.8 ± 26.1 x 10E3 cells versus PT ipsilateral:
183.2 ± 17.1 × 10E3 cells; p < 0.01). This difference was
primarily caused by CD45high leukocytes (Figure 2A) and,
to a lesser degree, by CD45int microglia (naive: 103.3 ±
28.9 × 10E3 cells and PT contralateral: 85.3 ± 20.6 × 10E3
cells versus PT ipsilateral: 124.5 ± 16.7 × 10E3 cells; p >
0.05). Compared to naive controls, experimental stroke
induced a 40 fold increase of F4/80+ macrophages within
the ipsilateral hemisphere (Figure 2B). The majority of these
cells did not co-express CD11c or major histocompatibility
complex (MHC)-II, but we also observed CD11c- or MHCII-
single positive and CD11c/MHCII-double positive macro-
phages (Figure 2C).
We found a comparable increase of monocytes and
Lin-/CD11c+ cDC (Figure 2D) within the ischemic hemi-
sphere. Finally, stroke induced a slight, but statistically sig-
nificant increase of pDC (naive: 135 ± 104 cells and PT
contralateral: 186 ± 105 cells versus PT ipsilateral: 524 ±
215 cells; p < 0.05)
Next, we differentiated Lin-/CD11c+ cDC by CD11b and
CD103 as classical markers for non-lymphoid tissue DCs.
Two major subpopulations responded to ischemic stroke: a
CD11b+/CD103- population and CD11b+/CD103+
cells (Figure 3A) that may resemble migratory and tol-
erogenic DCs in the intestinal lamina propria [14].
CD11b+/CD103+ cells were virtually absent in naive
Figure 1 Gating strategy for the analysis of brain leukocytes. Lineage (Lin) antibodies include CD3 (T cells), B220 (B cells, pDC), Ly6G (neutrophils)
and CD49b (NK cells, NKT cells). FSC-H, forward scatter height; FSC-A, forward scatter area; SSC-A, side scatter area; Ma, macrophages.
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sphere. Neither CD11b-/CD103- cells (Figure 3A) nor
CD11b+/CD103- and CD11b-/CD103+ cells (not shown)
expressed CD4 or CD8.
Approximately 75% of the Lin-/CD11c+ cells were also
positive for MHCII and could hence be categorized as
matured cDCs (Figure 3B). However, almost 20% of the
MHCII- cells were also CD11b+/CD103+, indicating that
at least a part of Lin-/CD11c+/MHCII- are DCs in pre-
mature state [15].
Discussion
After stroke, the immune system is challenged by a massive
release of brain antigens that are ultimately present in T
cell zones of cervical lymph nodes [8]. It is likely that
subsets of the mononuclear phagocyte system enter the
ischemic lesion, transport antigens to draining lymph
nodes and orchestrate the induction of immunity and
tolerance. To understand these processes, it is necessary to
dissect subsets, and eventually time course and fate of DC
after stroke.
The integrin CD11c is frequently used as bona fide
marker to study DC biology, but CD11c expression is
described on various leukocyte subsets including macro-
phages, granulocytes and NK cells [6]. In this study, almost
one-third of F4/80+ macrophages in the ischemic hemi-
sphere also expressed CD11c, possibly indicating an M1-
like pro-inflammatory phenotype [11]. The exclusive use ofCD11c is therefore not accurate to distinguish macrophages
and DC during post-stroke inflammation. The same applies
for MHCII that is increasingly expressed during DC matur-
ation [15], but also by activated macrophages [6].
There is insufficient data on non-lymphoid tissue DC
phenotypes under inflammatory conditions such as stroke,
but DC in tissues with physiological continuous antigen
exposure such as the lung or the gut may serve as a model.
Murine lung and intestinal macrophages express high levels
of F4/80 and varying levels of CD11c, whereas CD11c+DC
are predominantly F4/80- [14,16,17]. We therefore decided
to apply a two-step gating strategy to first separate macro-
phages by F4/80 expression before differentiating monocytes
by Lin-/F4/80-/CD11c-/CD11b+ and cDC by Lin-/F4/80-/
CD11c+. This approach is limited by the fact that infiltrating
Ly6Clow resident monocytes may also express CD11c [18]
and could finally be false positively quantified as
CD11b+/CD103- cDC. However, Co-staining with
MHCII revealed that the majority of Lin-/CD11c+ cells
are in fact mature DCs, whereas the remaining MHCII-
population may comprise of both, Ly6low resident mono-
cytes and Ly6Chigh monocytes that are differentiating and
maturing towards DC [19].
Six days after stroke, we found monocytes, macrophages,
cDC and, at a lower level, pDC significantly increased in
the ischemic hemisphere. The increase of cDC was primar-
ily driven by CD11b+/CD103- cells which are derived from
inflammatory monocytes and produce pro-inflammatory
Figure 2 Differentiation of mononuclear phagocytes after photothrombotic stroke (PT) in mice. (A), in both experiments, PT consistently
caused a significant increase of CD45high + leukocytes in the ipsilateral (ipsi) hemisphere. (B), subset analysis revealed a strong increase of F4/80+
macrophages which could be further categorized by CD11c and MHCII expression (C; experiment 2, n = 3). (D), monocytes (Mo) and Lin-/CD11c+ cDC
also significantly contribute to the inflammatory response to stroke. *p < 0.05, ** p < 0.01, ***p < 0.001 by one way ANOVA and Bonferronis’ post-hoc
test. Contra, contralateral.
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Figure 3 Subdifferentiation of Lin-/CD11c+ cells. (A), in the ipsilateral (ipsi) hemisphere, Lin-/CD11c+ cells were primarily composed of
CD11b+/CD103- and CD11b+/CD103+ cells. We found only few CD11b-/CD103+ and CD11b-/CD103- cells, but no CD4+ or CD8+ expression.
(B), Lin-/CD11c+ cells were predominantly MHCII+. CD11b+/CD103+ DC were enriched in the MHCII+ population (green), but also present among
MHCII- cells (black; experiment 2, n = 3). *p < 0.05, **p < 0.01 by one way ANOVA and Bonferronis’ post-hoc test. Contra, contralateral.
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colon [16]. By contrast, CD11b-/CD103+ cDC, that rather
emerge from circulating DC precursors [20,21] were
barely altered in the ischemic hemisphere. Finally, we
found a strong increase of CD11b+/CD103+ cDC in the
ischemic hemisphere, a subpopulation that is scarcely
present in naive brain tissue. These cells may resemble
CD11b+/CD103+ cDC in the intestines that express high
levels of CCR7, carry antigens toward draining lymph
nodes and promote tolerance to ingested antigens [14].
After stroke, emigrating CD11b+/CD103+ cDC may play apivotal role in the control of clinically relevant autoreactive
immune responses to brain antigens [3].
To our knowledge, this is the first report on dendritic
cell subsets during post-stroke inflammation. Some over-
lap may exist for Ly6Clow resident monocytes and
maturating MHCII- DC, but only the detection of deter-
mining transcription factors might help to overcome
these uncertainties [22]. Finally, we could identify a
CD11b+/CD103+ DC subset that is well-studied in the
mucosal immunity and may also adopt important func-
tions after stroke.
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